Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 28, 2024, titled "Zydus receives final approval from USFDA for Enzalutamide Capsules, 40 mg".
Press Release Sep 28 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Sep 27 2024
- Press Release Sep 13 2024
- Press Release Sep 10 2024
- Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days
- Press Release Aug 30 2024
Later from Zydus Lifesciences
- Press Release Oct 01 2024
- Press Release Oct 02 2024
- Press Release Oct 10 2024
- Press Release Oct 14 2024
- Press Release Oct 17 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences